Mark Vajaranant

492 total citations
8 papers, 369 citations indexed

About

Mark Vajaranant is a scholar working on Infectious Diseases, Emergency Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mark Vajaranant has authored 8 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 4 papers in Emergency Medicine and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mark Vajaranant's work include HIV/AIDS Research and Interventions (7 papers), HIV-related health complications and treatments (4 papers) and Maternal and fetal healthcare (2 papers). Mark Vajaranant is often cited by papers focused on HIV/AIDS Research and Interventions (7 papers), HIV-related health complications and treatments (4 papers) and Maternal and fetal healthcare (2 papers). Mark Vajaranant collaborates with scholars based in Puerto Rico, United States and Hungary. Mark Vajaranant's co-authors include Carmen Zorrilla, Ruth Tuomala, Bruce Thompson, Sheldon H. Landesman, Hunter Hammill, D. Heather Watts, Daner Li, Jane Pitt, Jennifer S. Read and Gina Brown and has published in prestigious journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes and Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology.

In The Last Decade

Mark Vajaranant

8 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Vajaranant Puerto Rico	7	329	173	118	76	64	8	369
Jenny Coley United States	9	197 0.6×	95 0.5×	90 0.8×	58 0.8×	65 1.0×	11	385
Beverly Bohannon United States	9	316 1.0×	119 0.7×	134 1.1×	79 1.0×	65 1.0×	18	401
Thalita Fernandes de Abreu Brazil	11	261 0.8×	86 0.5×	127 1.1×	66 0.9×	58 0.9×	40	368
Karoline Aebi‐Popp Switzerland	12	314 1.0×	122 0.7×	240 2.0×	62 0.8×	44 0.7×	37	435
Laura Byrne United Kingdom	9	307 0.9×	77 0.4×	164 1.4×	51 0.7×	45 0.7×	16	395
Cheryl Nikodem South Africa	8	244 0.7×	67 0.4×	120 1.0×	53 0.7×	73 1.1×	13	386
Haswell Jere Italy	9	245 0.7×	70 0.4×	132 1.1×	44 0.6×	70 1.1×	18	330
Abel Dushimimana United States	8	224 0.7×	55 0.3×	100 0.8×	60 0.8×	37 0.6×	12	334
Ricardo Hugo de Oliveira Brazil	11	245 0.7×	101 0.6×	82 0.7×	50 0.7×	37 0.6×	25	335
Nelly Briand France	9	239 0.7×	93 0.5×	81 0.7×	25 0.3×	36 0.6×	15	282

Countries citing papers authored by Mark Vajaranant

Since Specialization

Citations

This map shows the geographic impact of Mark Vajaranant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Vajaranant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Vajaranant more than expected).

Fields of papers citing papers by Mark Vajaranant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Vajaranant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Vajaranant. The network helps show where Mark Vajaranant may publish in the future.

Co-authorship network of co-authors of Mark Vajaranant

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Vajaranant. A scholar is included among the top collaborators of Mark Vajaranant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Vajaranant. Mark Vajaranant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Bryant, Allison, Robert M. Leighty, Jennifer S. Read, et al.. (2006). Predictors of Repeat Pregnancy Among HIV-1-Infected Women. JAIDS Journal of Acquired Immune Deficiency Syndromes. 44(1). 87–92. 17 indexed citations

2.

Watts, D. Heather, Daner Li, Hugh H. Tilson, et al.. (2006). Assessment of Birth Defects According to Maternal Therapy Among Infants in the Women and Infants Transmission Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 44(3). 299–305. 41 indexed citations

3.

Tuomala, Ruth, D. Heather Watts, Daner Li, et al.. (2005). Improved Obstetric Outcomes and Few Maternal Toxicities Are Associated With Antiretroviral Therapy, Including Highly Active Antiretroviral Therapy During Pregnancy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 38(4). 449–473. 130 indexed citations

4.

Read, Jennifer S., Ruth Tuomala, Eloi Kpamegan, et al.. (2001). Mode of Delivery and Postpartum Morbidity Among HIV-Infected Women: The Women and Infants Transmission Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 26(3). 236–245. 57 indexed citations

5.

Read, Jennifer S., Ruth Tuomala, Eloi Kpamegan, et al.. (2001). Mode of Delivery and Postpartum Morbidity Among HIV-Infected Women: The Women and Infants Transmission Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 26(3). 236–245. 42 indexed citations

6.

Cu‐Uvin, Susan, Joseph I. Harwell, Jane Garb, et al.. (2000). Multicenter Review of Protease Inhibitors in 89 Pregnancies. JAIDS Journal of Acquired Immune Deficiency Syndromes. 25(4). 306–311. 50 indexed citations

7.

Cu‐Uvin, Susan, Joseph I. Harwell, Jane Garb, et al.. (2000). Multicenter Review of Protease Inhibitors in 89 Pregnancies. JAIDS Journal of Acquired Immune Deficiency Syndromes. 25(4). 306–311. 29 indexed citations

8.

Stratton, Pamela, Prabodh K. Gupta, Katherine Riester, et al.. (1999). Cervical Dysplasia on Cervicovaginal Papanicolaou Smear Among HIV-1-Infected Pregnant and Nonpregnant Women. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 20(3). 300–307. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact